Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

A former “D” student from Norway, he made his mark at G.E.’s Research Lab in the U.S., in part by confirming a pivotal theory ...